MedPath
HSA Approval

SOTYKTU FILM-COATED TABLETS 6 MG

SIN16939P

SOTYKTU FILM-COATED TABLETS 6 MG

SOTYKTU FILM-COATED TABLETS 6 MG

February 4, 2024

BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

L04AF07

deucravacitinib

Manufacturer Information

BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Hovione Farmaciencia S.A.

Patheon Inc.

Active Ingredients

Deucravacitinib

6.00 mg

Deucravacitinib

Documents

Package Inserts

Sotyktu Tablet PI.pdf

Approved: February 4, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SOTYKTU FILM-COATED TABLETS 6 MG - HSA Approval | MedPath